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Polybrominated diphenyl ethers (PBDEs) are 
high-production-volume chemicals that have 
been widely used as flame retardants in elec-
tronic equipment, carpet, and the polyure-
thane foam used in furniture (Darnerud et al. 
2001; Frederiksen et al. 2009; Sjodin et al. 
2003). Unlike reactive flame retardants, which 
are mixed into plastic before polymerization to 
form a covalent bond with the polymer matrix, 
PBDEs are additive flame retardants that are 
mixed with the finished polymer. Additives 
have a greater potential to leach from the prod-
uct into the environment over the life cycle of 
the product (Sjodin et al. 2003).
Commercial PBDE formulations are 
named by their average degree of bromina-
tion. The pentaBDE formulation, used in 
polyurethane foam in carpet padding and fur-
niture, contains mainly tetra- through hexa-
BDEs. The octa and deca formulations are 
used in the hard plastics of electronic casings 
and similar products. The octa formulation 
includes octa- and hepta-congeners, whereas 
decaBDE is almost entirely BDE-209. The 
formulations with 7–10 bromines have rela-
tively short half-lives in humans compared 
with congeners with shorter bromine chains 
(Lorber 2008; Thuresson et al. 2006). The 
penta and octa formulations were banned in 
Europe at the turn of the century and volun-
tarily withdrawn in the United States in 2004 
because of their persistence in the environ-
ment and unknown safety (Lind et al. 2003; 
Lorber 2008; Meironyte et al. 1999; Noren 
and Meironyte 2000). DecaBDE continues 
to be produced in North America and much 
of Europe (Darnerud et al. 2001; de Wit 
2002; Hale et al. 2003; Sjodin 2004; Sjodin 
et al. 2003).
Detection of PBDEs in the environ-
ment and in human tissues has dramatically 
increased over the past 20 years due to high 
production and use as well as persistence 
in the environment (Darnerud et al. 2001; 
Frederiksen et al. 2009; Meironyte et al. 
1999; Noren and Meironyte 2000; Petreas 
et al. 2003; Sjodin et al. 2004a). Levels in the 
United States and Canada more than dou-
bled in the late 1990s and are estimated to be 
among the highest in the world (Betts 2002; 
Darnerud et al. 2001; Sjodin et al. 2003, 
2004a, 2008a, 2008b; Zhu and Hites 2004).
The ubiquitous nature of these chemi-
cals is demonstrated by measurable levels in 
samples of air, water, dust, and sewage sludge, 
but the paths by which humans are exposed 
to PBDEs are still unclear (Hale et al. 2002, 
2003; Watanabe and Sakai 2003). Although 
diet may contribute to adult PBDE levels 
(Darnerud et al. 2001; Fraser et al. 2009), 
exposure to dust in the indoor environ-
ment may be a more significant contributor 
(Johnson-Restrepo and Kannan 2009; Sjodin 
et al. 2008a). This differs from traditional 
persistent organic pollutants, such as poly-
chlorinated biphenyls (PCBs), for which diet 
is the main route of exposure (Frederiksen 
et al. 2009; Lorber 2008).
For infants, the greatest source of PBDE 
exposure is believed to be through their moth-
ers, both in utero and from breast-feeding 
(Johnson-Restrepo and Kannan 2009; Toms 
et al. 2008). High PBDEs have been meas-
ured in the placenta, cord blood, and liver 
tissue (Costa and Giordano 2007; Doucet 
et al. 2009; Frederiksen et al. 2009; Schecter 
et al. 2007). Maternal and cord blood levels 
are highly correlated, as are maternal blood 
and breast milk levels (Guvenius et al. 2003; 
Mazdai et al. 2003). Because the compounds 
distribute in tissues based on the lipid con-
centration, the high lipid concentration in 
milk enhances exposure for the nursing infant 
(Darnerud et al. 2001).
The few studies measuring PBDEs in 
breast milk in the United States have occurred 
between 2002 and 2006 (Table 1) (Johnson-
Restrepo et al. 2007; Schecter et al. 2003; She 
et al. 2007; Wu et al. 2007). Most of these 
studies have been small and provided little 
information about how PBDE levels varied 
among individuals or with duration of breast-
feeding. We report PBDE concentrations in 
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Ba c k g r o u n d: Reported polybrominated diphenyl ether (PBDE) concentrations in human samples 
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sample was analyzed for 83 women still lactating 12 months postpartum. PBDE concentrations in 
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lipid, with a median of 28 ng/g lipid. Concentrations of most individual PBDE congeners and the 
sum of BDEs 28, 47, 99, 100, and 153 (ΣPBDE) were lower among mothers > 34 years of age com-
pared with those 25–29 years of age and higher among mothers with high compared with normal 
BMI, after adjustment for other covariates. Parity was not associated with PBDE concentration. 
The change in ΣPBDE concentration in milk between 3 and 12 months postpartum was highly 
variable (median increase, 14%; interquartile range, –26% to 50%).
co n c l u s i o n s: PBDEs were detected in nearly all human milk samples, varying by maternal weight 
and age and over the course of breast-feeding.
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milk from a large sample of women in central 
North Carolina (USA). We evaluated the cor-
relation between PBDEs and other persistent 
pollutants. We also assessed factors that might 
contribute to individual variability, including 
age, parity, and body mass index (BMI), and 
calculated the change in milk concentration 
over the first postpartum year.
Materials and Methods
Study population. Participants in this anal-
ysis were women who participated in the 
later years of the Pregnancy, Infection, and 
Nutrition (PIN) Study and PIN Postpartum 
Study. These two studies followed central 
North Carolina women from early pregnancy 
through 12 months postpartum between 
2001 and 2005 (PIN 2009). Women were 
recruited into PIN from the University of 
North Carolina prenatal care clinics and 
delivered their infants at University of North 
Carolina hospitals (64% of eligible women 
participated during pregnancy). Seventy-three 
percent of eligible participants from the PIN 
Study (delivered a singleton infant without 
major birth defects) continued in the PIN 
Postpartum Study. In January 2004, the PIN 
Babies Study began collecting milk samples 
at 3 and 12 months postpartum from lactat-
ing women. Between 2004 and 2006, 331 
of 589 eligible women were lactating, and so 
were eligible to contribute milk samples at 
3 months postpartum.
A research team visited the women’s 
homes at 3 and 12 months postpartum to 
collect milk, take anthropometric measure-
ments of the mother, assess her percent body 
fat using a bioelectrical impedance scale, and 
interview her about her diet, psychosocial 
health, physical activity, lifestyle, and breast-
feeding practices. Before the scheduled visit, a 
milk collection kit was mailed to mothers who 
said they were breast-feeding. Women were 
instructed to empty both breasts by pumping 
at around 1000 hours on the morning of her 
scheduled home visit, gently mix the milk, 
use the plastic pipette to transfer milk into 
Eppendorf tubes, and freeze the milk until the 
staff arrived later that day. Milk samples were 
transported on ice and then stored at –80°C. 
All study protocols were approved by the 
Institutional Review Board at the University 
of North Carolina–Chapel Hill, and all par-
ticipants provided informed consent.
Analysis of PBDEs, PCBs, and p,p´-DDE 
(dichlorodiphenyldichloroethylene) in milk 
was conducted at the Organic Analytic 
Toxicology Branch of the National Center 
for Environmental Health at the Centers for 
Disease Control and Prevention using pre-
viously described methodology (Sjodin et al. 
2004b). Milk samples underwent solid-phase 
dispersion onto diatomaceous earth, and inter-
nal standards were added. Lipids and target 
analytes were extracted using a solid-phase 
extraction system, in which the sample on 
diatomaceous earth was dried by pressurized 
nitrogen and extracted with dichloromethane. 
Lipid content was determined gravimetri-
cally, and the final analytical determination of 
PBDEs, PCBs, and p,p´-DDE was performed 
by gas chromatography/isotope-dilution high-
resolution mass spectrometry. Two control and 
two blank samples were added to each batch 
of 16 unknown samples for quality control. 
Laboratory quality assurance practices were 
regularly monitored (Sjodin et al. 2004b).
Data analysis. PBDEs in the milk samples 
provided at 3 months postpartum appeared 
log-normally distributed; thus medians, 
quartiles, and total range are reported here. 
The concentration of target analytes were lipid 
normalized and are reported as nanograms 
per gram of milk lipids. Samples below the 
limit of detection (LOD) were imputed three 
ways in the calculations: 0,  , 2 LOD/  and 
/2 median LOD ^h . The method of includ-
ing observations below the LOD did not 
affect the results; thus only results based on 
/2 median LOD ^h  are presented here.
The congeners detected in more than 70% 
of the individuals’ samples (BDEs 28, 47, 99, 
100, and 153) were summed to produce a 
cumulative measure (ΣPBDE). Spearman cor-
relation coefficients (rS) were calculated to assess 
the correlations among the PBDE congeners 
and among ΣPBDEs, ΣPCBs, and p,p´-DDE. 
For the women providing samples at 3 and 
12 months postpartum, the correlation between 
the two samples was calculated, along with the 
percent change between 3 and 12 months: 
[(12-month concentration) – (3-month con-
centration)]/(3 month concentration) × 100%]. 
PBDE body burden (micrograms) was esti-
mated as [concentration of PBDE (nanograms 
Table 1. Summary of studiesa reporting ΣPBDE concentrations in human milk samples from the United States.
Year of sample (no.)
Characteristic 2002 (47) 2003 (40) 2004 (38) 2004 (46) 2004–2006 (301)
PBDE concentration
Mean ± SD 74 ± 103 96 76 ± 304 NA 89 ± 146.7
Median 34 50 20 30 51
Range (ng/g lipid) 6–419 6–321 0.1–1910 4–264 1–2,010
Mean percent lipid 3 4 2 ± 2 NA 2
Mother’s age (mean years ± SD)  29 ± 6 31 ± 6 35 ± 5 NA 31 ± 5
Timing of collection (weeks postpartum) NA 2–8 NA 2–8 12–24
Location Austin, TX Pacific Northwest Central MA Boston, MA Central NC
Reference Schecter et al. 2003 She et al. 2007 Johnson-Restrepo et al. 2007 Wu et al. 2007 Present results
NA, not available from published manuscript. 
aStatistics here differ slightly from those originally published because of rounding. The congeners comprising ΣPBDE may differ slightly among studies but generally include the conge-
ners included in the present study: BDE-28, -47, -99, -100, and -153.
Table 2. Lipid-adjusted concentrations of brominated flame retardants (ng/g lipid) in 303 human milk samples collected around 3 months postpartum from central 
North Carolina, 2004–2006.
PBDE congener IUPAC number Detectable [no. (%)] Minimum 25th percentile Median 75th percentile Maximum
2,4,4-Tri-BDE 28 295 (97) ND 1 2 4 50
2,2´,4,4´-Tetra-BDE 47 302 (99) ND 16 28 54 1,430
2,3´,4,4´-Tetra-BDE 66 139 (46) ND ND ND 0.5 11
2,2´,3,4,4´-Penta-BDE 85 196 (65) ND ND 0.5 1 27
2,2´,4,4´,5-Penta-BDE 99 278 (92) ND 3 5 11 299
2,2´,4,4´,6-Penta-BDE 100 300 (99) ND 2 5 10 188
2,2´,4,4´,5,5´-Hexa-BDE 153 302 (99) ND 3 6 14 229
2,3,4,4´,5,6-Hexa-BDE 154 163 (54) ND ND 0.3 0.7 13
2,2´,3,4,4´,5´,6-Hepta-BDE 183 35 (12) ND ND ND ND 15
ΣPBDEs 303  1.2 28 51 102 2,010
ND (nondetected) values are treated as (median LOD/square root of 2) in the calculation of the mean.  PBDE in human milk
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per gram lipid)] × [maternal body weight 
(kilograms)] × (body fat percentage at 3 or 12 
months). Because the data were highly right-
skewed, the sign test was used, instead of a 
paired t-test, to test the null hypothesis that the 
median change between 3 and 12 months post-
partum equaled zero (α = 0.05).
We used linear models (PROC GLM, 
version 9.1; SAS Institute Inc., Cary, NC) 
to assess whether individual characteristics 
were associated with PBDE levels and to 
calculate adjusted geometric means for each 
category of each covariate, including mater-
nal age (< 25, 25–29, 30–34, ≥ 35 years), 
parity (0, ≥ 1), race (nonwhite, white), and 
pre  pregnancy BMI (low, < 19.8 kg/m2; 
normal, 19.8 to ≤ 26.0 kg/m2; overweight, 
> 26.0 to ≤ 29.0 kg/m2; obese, > 29.0 kg/m2). 
Because PBDEs are stored in fat and prepreg-
nancy BMI reflects a woman’s long-term fat 
stores, results are presented for prepregnancy 
BMI. However, we compared these results 
with two additional modeling approaches: 
a) adjusting for pregnancy weight gain and 
percent body fat at 3 months postpartum, 
and b) substituting prepregnancy BMI with 
3-month postpartum BMI. The primary rea-
son for not focusing on postpartum BMI 
measures is that interpreting the effects of 
postpartum BMI on long-term chemical stor-
age medium is confounded by temporary fat 
and fluid gains associated with pregnancy.
Results
Study participants were primarily college 
educated (82%) and white (86%). The mean 
maternal age was 30.7 ± 4.9 years, and 52% 
were primiparous. Three hundred four (62%) 
of the 334 lactating women provided a milk 
sample around 3 months postpartum (mean 
± SD, 3.5 ± 0.6 months postpartum); PBDEs 
were successfully quantified in all but one. 
Eighty-three women (27%) also provided a 
milk sample at 12 months postpartum. Among 
congeners detected in > 70% of the samples, 
ΣPBDEs ranged from 1 to 2,010 ng/g lipid in 
the 3-month samples (Table 2). BDE-47 was 
present in highest concentration, which ranged 
from < LOD to 1,430 ng/g lipid. Among the 
congeners present in > 70% of samples, BDEs 
28, 47, 99, and 100 were highly correlated 
with each other (rS range, 0.8–0.9, p < 0.0001) 
and moderately correlated with BDE-153 (rS 
range, 0.6–0.8, p < 0.0001; data not shown). 
ΣPBDE was not correlated with ΣPCBs 
(rS = –0.1, p = 0.3) or p,p´-DDE (rS = –0.1, 
p = 0.2) (data not shown).
The milk concentrations of most indi-
vidual PBDE congeners and ΣPBDE varied 
by maternal age and BMI. Mean concentra-
tions were lower among women > 34 years 
of age compared with women 25–29 years 
of age (Figure 1) and higher among obese 
women compared with those of normal BMI 
(Figure 2), after adjustment for other cova-
riates. Prepregnancy and 3-month postpar-
tum BMI were highly correlated (rS = 0.9, 
p < 0.0001); consequently, associations 
between BMI and PBDE concentrations were 
the same regardless of whether we modeled 
prepregnancy or postpartum BMI or adjusted 
models for prenatal weight gain and per-
cent body fat at 3 months postpartum. We 
observed no differences by parity or race (data 
not shown), but most women were Caucasian, 
limiting interpretation. Bearing in mind that 
all women in this study breast-fed at least 
3 months in order to provide a sample, PBDE 
concentrations were not associated with breast-
feeding duration (data not shown).
Among the 83 women with two sam-
ples, the PBDE concentrations were highly 
correlated between milk samples taken at 3 
and 12 months (rS = 0.7–0.8, p < 0.0001; 
data not shown). The median ΣPBDE con-
centration at 3 months was 47 ng/g lipid 
(range, 8–2,010 ng/g lipid). Between 3 and 
12 months, the change in ΣPBDE milk con-
centration ranged from –88% to 536%, but 
the median change (14%; interquartile range, 
–26% to 50%) was not significantly different 
from zero (p = 0.2). The magnitude and direc-
tion of change for most congeners varied con-
siderably among individuals (Figure 3), but 
for BDE-153, the concentration significantly 
increased from 3 to 12 months postpartum 
(median change, 18%; interquartile range, 
–15% to 70%; p = 0.005). Considering wom-
en’s percent body fat along with their milk 
concentration, we estimated women’s median 
ΣPBDE body burden at 3 months to be 
1,002 µg (interquartile range, 494–2,090 µg). 
The magnitude and direction of change in 
estimated body burden between 3 and 
12 months varied among women (Figure 4), 
but the median change was not significantly 
different from zero for any congener or for 
ΣPBDE. Between 3 and 12 months post-
partum, most women’s percent body fat 
decreased (median change, –6%; interquartile 
range, –12% to 0.6%; p < 0.0001), but the 
change was not associated with change in 
PBDE concentrations (data not shown). The 
lipid content in milk did not change mark-
edly between 3 and 12 months of lactation 
(median change, –18%; interquartile range, 
–54% to 40%; p = 0.4).
Discussion
ΣPBDE concentrations ranged from 1 to 
2,010 ng/g lipid in this large study of North 
Carolina breast milk samples collected 
between 2004 and 2006. These concentrations 
are higher than milk concentrations reported 
by most similarly timed studies from the 
United States (Johnson-Restrepo et al. 2007; 
Figure 1. PBDE congener concentrations stratified by age (x-axis; years) and 
adjusted for parity, prepregnancy BMI, and race. Numbers above the bars are 
means; error bars indicate 95% confidence intervals. Sample sizes for each 
age group: 32 for < 25 years, 88 for 25–29 years, 130 for 30–34 years, and 54 for 
≥ 35 years. 
*p < 0.05 in generalized linear model comparing with reference group (25–29 years).
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Schecter et al. 2003; She et al. 2007; Wu et al. 
2007) and considerably higher than those in 
reports from abroad (reviewed by Erdogrul 
et al. 2004; Frederiksen et al. 2009; Johnson-
Restrepo et al. 2007; Lind et al. 2003; Toms 
et al. 2007). Concentrations in milk samples 
from this study were also higher, comparing 
lipid-adjusted concentrations (nanograms per 
gram milk lipid), than were corresponding 
concentrations in blood samples provided by 
mostly African-American pregnant women 
in a Maryland study during the same time 
period (Herbstman et al. 2007). The higher 
concentrations reported in these North 
Carolina samples could have resulted from a 
slightly younger population, regional differ-
ences in regulation and use of PBDEs across 
the United States, or simply a greater range 
revealed by the larger study size. Differences 
are not likely to be due to dramatic temporal 
increases over such a short period of time.
As reported in other studies, BDE-47 was 
present in highest concentration, followed by 
BDEs 99, 100, and 153, which we detected 
in nearly all samples. We detected BDEs 66, 
85, 154, and 183 in < 70% of the samples. 
In this study, ΣPBDE included only conge-
ners present in > 70% of the samples. This 
method is somewhat conservative and may 
underestimate total exposure, but minimizes 
assumptions inherent when summing data 
below the LOD. PBDE concentrations were 
not correlated with PCB or DDE concentra-
tions, which supports reports suggesting that 
sources of exposure for these persistent pol-
lutants are different (Frederiksen et al. 2009; 
Herbstman et al. 2007; Kiviranta et al. 2004; 
Schecter et al. 2005).
PBDE concentrations in milk varied by 
age and BMI but were not affected by par-
ity or race. We had limited power to detect 
variability by race because the study popula-
tion was predominantly white. We also lacked 
information needed to evaluate the effect of 
breast-feeding history among parous women, 
although it seems likely that most women 
breast-feeding their second child also breast-
fed their first. When adjusted for other covari-
ates, we observed the lower milk concentration 
among the oldest women compared with those 
25–29 years of age for all congeners except 
BDE-28. Milk concentrations were signifi-
cantly higher among obese women compared 
with those of normal weight for BDEs 47, 99, 
and 100, but were also slightly higher in milk 
from women with low BMI. The variabil-
ity by weight and age, and across congeners, 
is similar to observations of prenatal serum 
samples from Maryland women (Herbstman 
et al. 2007) and general-population serum 
samples from the 2003–2004 National Health 
and Nutrition Examination Survey (Sjodin 
et al. 2008b). Higher concentrations among 
women in younger age groups may suggest 
that the environment and habits of younger 
generations expose them to higher levels of 
PBDEs than do those of women ≥ 35 years 
of age. Higher concentrations among heavier 
women may reflect the lipophilic nature of the 
chemicals. The slightly different pattern for 
BDE-153 may reflect differences in exposure 
sources and/or metabolism compared with 
other congeners.
We assessed variability by individual char-
acteristics only among the congeners detected 
in > 70% of the participants. We were unable 
to measure BDE-209, the primary congener of 
the decaBDE formulation, which is the only 
brominated flame retardant still produced in 
the United States. BDE-209 is stable but less 
likely to bioaccumulate and be detected at 
remarkable levels in human tissue compared 
with the lower brominated congeners because 
of its short half-life (i.e., 2 weeks in humans) 
(Sjodin et al. 2003; Thuresson et al. 2006). 
According to the Agency for Toxic Substances 
and Disease Registry (2004), “the lower bro-
minated PBDEs are much more likely than 
decaBDE to be stored in the mother’s body 
and released during pregnancy, cross the pla-
centa, and enter fetal tissues. Because lower 
brominated PBDEs dissolve readily in fat, 
they can accumulate in breast milk fat and be 
transferred to babies and young children.”
For infants, the primary source of expo-
sure to PBDEs is breast milk. Darnerud 
et al. (2001) estimated that infant exposure 
in Sweden in the late 1990s through breast 
milk averaged 0.11 µg/day for ΣPBDE, based 
on Swedish data assuming 3.7% fat in milk 
and 0.7 L/day consumption. The actual vol-
ume of milk consumed by the children in 
our study has not been determined; however, 
if we apply the same algorithm and substi-
tute the median concentration observed in 
the 3-month samples from North Carolina, 
median daily exposure to infants through 
breast milk would be considerably higher: 
0.8 µg BDE-47 and 1.5 µg ΣPBDEs.
Among women with samples at 3 and 
12 months postpartum, the concentrations 
in milk were highly correlated and, for most 
congeners, did not significantly change. The 
range of change among all congeners was very 
large and tended to be in a positive (increasing) 
direction. Our results from this large sample 
generally differ from those of a small case series 
studying depuration, which reported subtle 
decreases in concentration over the course of 
lactation among eight women (Hooper et al. 
2007). For BDE-153, however, the median 
concentration in our data significantly 
increased between 3 and 12 months postpar-
tum. It is unclear why BDE-153 increased 
whereas other congeners did not. It may reflect 
variability in the distribution and skew of the 
change among congeners, which can affect the 
statistical power to detect change. It could also 
reflect different levels of continuous exposure 
over the postpartum period among the conge-
ners. However, it is also important to consider 
possible variability in the metabolism and stor-
age of the congeners. At 3 months postpartum, 
retention of excess fat and fluid from pregnancy 
may dilute the circulating chemical concentra-
tion and the corresponding concentration in 
milk samples. By 12 months, women have less 
pregnancy-associated fat and fluid retention, so 
some chemicals mobilized from fat stores could 
become more concentrated in milk. Differences 
in the level of change among congeners over 
the course of lactation may reflect variability in 
the metabolism, storage, and release of particu-
lar congeners from fat. Studies of other pollut-
ants have suggested that weight loss increases 
chemical concentrations measured in fat tissue 
(Chevrier et al. 2000; Pelletier et al. 2003). In 
this cohort, neither maternal weight gain dur-
ing pregnancy nor percentage of body fat was 
associated with PBDE concentration in milk. 
Figure 4. Percent change in estimated maternal 
PBDE body burden between 3 and 12 months post-
partum, calculated as concentration (ng/g lipid) 
× body weight (kg) × body fat percentage (µg). 
Squares represent median percent change; small 
horizontal bars represent the 25th and 75th per-
centiles; and vertical bars display the spread of the 
data between the 5th and 95th percentiles.
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Figure 3. Percent change in PBDE concentration in 
milk between 3 and 12 months postpartum. Squares 
represent median; small horizontal bars represent 
the 25th and 75th percentiles; and vertical bars 
display the spread of the data between the 5th and 
95th percentiles. 
*p < 0.05 for the sign test, testing the null hypothesis that 
the median percent change equals zero.
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Furthermore, changes in the woman’s percent-
age of body fat postpartum were not associated 
with changes in milk PBDE concentration.
All women in this study breast-fed at least 
3 months, which was required to enter the 
study. Among these women, PBDE concen-
tration was not associated with breast-feeding 
duration through 12 months postpartum. 
However, we were unable to assess whether 
exposure to PBDEs could impair a woman’s 
ability to initiate breast-feeding or decrease 
milk supply enough cause her to discontinue 
breast-feeding before 3 months postpartum, 
when women entered our study.
This is the largest study of breast milk 
PBDE concentration in the United States to 
date and the only one that evaluated differ-
ences by individual characteristics such as age, 
BMI, parity, and duration of breast-feeding. 
However, this study was limited to mostly 
Caucasian, well-educated mothers from cen-
tral North Carolina. Other U.S. studies of 
PBDE concentrations in breast milk also 
included predominantly white and well-
  educated populations (She et al. 2007; Wu 
et al. 2007), which is reflective of breast-feed-
ing women in the United States (van Rossem 
et al. 2009). Although there is no reason to 
suspect that this North Carolina population 
would systematically differ from others, the 
data should be interpreted as regional and not 
representative of the United States.
The persistence of PBDEs raises our vigi-
lance for potential adverse environmental and 
human health consequences. Similar persis-
tent organic pollutants such as p,p´-DDE and 
PCBs have been extensively investigated over 
the past 20–30 years for reproductive and 
developmental toxicity (Branchi et al. 2003; 
Tilson and Kodavanti 1997, 1998; Tilson 
et al. 1990, 1998), resulting in restrictions 
on many compounds in the United States 
(Cordle et al. 1982). Although levels of these 
other organic pollutants are steadily decreas-
ing, levels of PBDEs are still elevated in the 
United States compared with other countries 
with limited recent use.
The consequences of exposure to PBDEs 
are unknown. Rodent studies have suggested 
that perinatal exposure to PBDEs may cause 
learning delays and behavioral problems that 
persist into adulthood, possibly worsening 
with age (Eriksson et al. 2001a, 2001b, 2002; 
Rice et al. 2007; Viberg et al. 2002, 2003a, 
2003b, 2004). Most rodent studies have 
focused on the pentaBDE congeners, exposing 
mice during gestation and soon after birth to 
various doses.
To date, little information is available to 
assess human health effects. Given the exten-
sive nutritional and immunologic benefits 
of breast milk, promotion of breast-feeding 
as the best method for infant feeding should 
continue (Oddy 2001; Schack-Nielsen and 
Michaelsen 2007). However, timely stud-
ies are needed to continue to monitor levels, 
to evaluate health effects, and to minimize 
exposure to all pervasive, persistent pollutants 
(Hooper and She 2003).
Ideally, as PBDE containing products 
exit the market, levels will begin to decline 
in the United States, as they have in Europe 
and other areas where use ended in the late 
1990s (Lind et al. 2003). However, because 
household products containing PBDEs will 
continue to be in use for some time, it is 
important to observe generations with greater 
exposure and monitor whether adverse health 
outcomes are associated with high-level expo-
sures, especially among the most vulnerable 
populations. Human milk samples offer a 
minimally invasive opportunity to monitor 
population level trends in PBDE exposure 
in the coming years (Hooper and She 2003; 
Meironyte et al. 1999; Wu et al. 2009).
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